Related Experiment Video
Updated: Aug 15, 2026

Generation of Fluorescent Protein Fusions in Candida Species
Published on: March 4, 2017
[Systemic Candida albicans infection with neuromeningeal complication in a premature infant]
1Service de Neurochirurgie, Hôpital de Hautepierre, Strasbourg. p.espo@wanadoo.fr
Introduction:
Systemic maternal-fetal Candida albicans infections are uncommon diseases with a poor outcome. An associated cerebromeningeal infection increases morbidity. We present a case of neuromeningeal candidiasis following systemic neonatal infection in a premature infant. Management and therapeutic difficulties are outlined.
Observation:
The patient was a male infant born preterm at 30 weeks gestation. During his first week of life, he developed a systemic infection with an associated symptomatic hydrocephalus. Systemic candidaisis with neuromeningeal complication was diagnosed five weeks later. Despite treatment including cerebrospinal fluid (CSF) shunting and antimycotic medications (flucytosin and amphotericin B), the candidal infection did not resolve. Infectious and mechanical complications of the CSF drainage were treated by several surgical interventions during the following months. At 10 months of life, there was clinical and laboratory evidence of active persistent neuromeningeal candidaisis. Finally, candidal infection was eradicated with intravenous administration of fluconazole. After five year follow-up, the intellectual and psychological status of the patient was quite satisfactory, and no neurological deficits were found on clinical examination.
Discussion:
Management of neuromeningeal candidaisis in premature infants is a challenging task particularly because of delayed diagnosis. Candida infection should routinely be suspected in cases of systemic infection with neurological impairment in premature infants. Fluconazole may constitute an efficient therapeutic option.
Insights
Systemic Candida albicans infections in premature infants, especially with brain and meningeal involvement, are dangerous. Fluconazole successfully treated a persistent case, showing promise for managing this rare neonatal condition.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Neurology
Background:
- Systemic maternal-fetal Candida albicans infections are rare but severe neonatal conditions.
- Neuromeningeal candidiasis significantly increases infant morbidity and mortality.
- Early diagnosis and management are critical for favorable outcomes.
Observation:
- A preterm infant (30 weeks gestation) developed systemic candidiasis with hydrocephalus and subsequent neuromeningeal complication.
- Initial treatments with cerebrospinal fluid (CSF) shunting, flucytosine, and amphotericin B failed to resolve the infection.
- Persistent infection required prolonged treatment, including surgical interventions for CSF drainage complications.
Findings:
- Intravenous fluconazole ultimately eradicated the persistent Candida infection.
- The infant showed satisfactory intellectual and psychological status with no neurological deficits after a five-year follow-up.
- Delayed diagnosis posed significant management and therapeutic challenges.
Implications:
- Candida infection should be suspected in premature infants with systemic infections and neurological impairment.
- Fluconazole represents a potentially effective therapeutic option for refractory neuromeningeal candidiasis in neonates.
- This case highlights the complexities in managing invasive fungal infections in vulnerable preterm infants.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Bacterial Meningitis I: Introduction
Cytomegalovirus Disease
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction
